The reasons Tesla's stock is under pressure are numerous. For one, numbers on Tesla sales from important overseas markets have come in soft to kick off the year. The readings have triggered some ...

The new ETF pairs a leveraged long holding in electric car manufacturer Tesla, offering investors 200% of the stock's upside ... electric vehicle lightweight materials market is witnessing ...

During the year ended December 31, 2024, the Company sold 31 properties for gross proceeds of $13.1 million and recorded a net gain of $5.9 million on the dispositions, including seven properties for ...

Bridgewater Associates made a fresh bet on EV maker Tesla Inc. late last year, as it exited memory chip maker Micron ...

A 23% return for the S&P 500 last year was certainly nothing to sniff at, but T. Rowe Price's $10.41 billion Science & Technology Fund PRSCX blew that out of the water with a 40.3% gain. Granted one ...

Tesla's (TSLA) stock has known only one direction in February: reverse. Shares of the Elon Musk-led EV maker dropped another 2% to $321 each in pre-market trading on Wednesday, continuing an ...

A 23% return for the S&P 500 last year was certainly nothing to sniff at, but T. Rowe Price's $10.41 billion Science & Technology Fund PRSCX blew that out of the water with a 40.3% gain. Granted one ...

Tariffs are expected to cause the cost of many everyday household items to rise. In anticipation of this, many homeowners are ...

NASCAR has no shortage of storylines headed into its 76th season and the biggest one is the federal court showdown between the stock car series and NBA Hall of Famer ...

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts and in providing software-enabled services and subscriptions. It operates ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci ...